Related Experiment Videos
Platelet serotonin concentration and monoamine oxidase activity in unmedicated chronic schizophrenic and in
Psychological Medicine
|February 1, 1977
Abstract:
Elevated blood serotonin, perhaps secondary to reduced platelet MAO, has been reported in a group of chronic schizophrenic patients. We have failed to find elevated platelet serotonin, or any relationship between platelet serotonin and MAO either in a group of unmedicated chronic schizophrenic patients or in a group of schizoaffective patients. Possible reasons for these discrepancies are discussed.
Insights
This study found no elevated blood serotonin or link to monoamine oxidase (MAO) in unmedicated schizophrenia patients. These findings contradict previous reports on serotonin levels in chronic schizophrenia.
Area of Science:
- Neuroscience
- Psychiatry
- Biochemistry
Background:
- Previous research suggested elevated blood serotonin in chronic schizophrenia, potentially linked to reduced platelet monoamine oxidase (MAO).
- However, these findings were not consistently replicated across all patient groups or studies.
Purpose of the Study:
- To investigate platelet serotonin and monoamine oxidase (MAO) levels in unmedicated chronic schizophrenic patients.
- To examine the relationship between platelet serotonin and MAO in schizoaffective patients.
- To address discrepancies in previous research on serotonin in schizophrenia.
Main Methods:
- Assessed platelet serotonin levels in unmedicated chronic schizophrenic and schizoaffective patients.
- Measured platelet monoamine oxidase (MAO) activity.
- Analyzed the correlation between serotonin and MAO levels within these patient groups.
Main Results:
- No significant elevation in platelet serotonin was found in the unmedicated chronic schizophrenic or schizoaffective patient groups.
- No correlation was identified between platelet serotonin levels and MAO activity in either patient group.
- The study failed to replicate previous findings of elevated serotonin in schizophrenia.
Conclusions:
- The findings do not support the hypothesis of elevated platelet serotonin in unmedicated chronic schizophrenic or schizoaffective patients.
- Discrepancies with prior research may be due to differences in patient populations, medication status, or methodologies.
- Further research is needed to clarify the role of serotonin and MAO in schizophrenia pathophysiology.